Assessing quality of diabetes care by measuring longitudinal changes in hemoglobin A1c in the veterans health administration

Health Services Research

Volumn 40, Issue 6 I, 2005, Pages 1818-1835

  Thompson, Wes ^b   Wang, Hongwei ^c   Xie, Minge ^c   Kolassa, John ^c   Rajan, Mangala ^d   Tseng, Chin Lin ^d   Crystal, Stephen ^c   Zhang, Quanwu ^d   Vardi, Yehuda ^c   Pogach, Leonard ^d   Safford, Monika M ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c RUTGERS UNIVERSITY   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Diabetes; Glycemic control; Longitudinal analysis; Performance measures; Quality of care

Indexed keywords

HEMOGLOBIN A1C; INSULIN;

ADULT; AGED; ARTICLE; CASE MIX; DIABETES CONTROL; DIABETES MELLITUS; FEMALE; HEALTH CARE FACILITY; HEALTH CARE QUALITY; HEALTH CARE SYSTEM; HEMOGLOBIN DETERMINATION; HUMAN; INSULIN TREATMENT; LABORATORY TEST; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; SOLDIER;

AGED; COMORBIDITY; DIABETES MELLITUS; FEMALE; HEALTH SERVICES RESEARCH; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; QUALITY OF HEALTH CARE; SEVERITY OF ILLNESS INDEX; SOCIOECONOMIC FACTORS; UNITED STATES; UNITED STATES DEPARTMENT OF VETERANS AFFAIRS;

EID: 29244465876     PISSN: 00179124     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1475-6773.2005.00439.x     Document Type: Article

References (28)

1. American Diabetes Association. 2004. "Clinical Practice Recommendations 2004." Diabetes Care 27 (suppl): S92-3.
2. Berlowitz, D. R., A. Ash, R. Friedman, E. Hickey, B. Kader, and M. A. Moskowitz. 1998. "Problems in Assessing Diabetes Control in an Ambulatory Setting." American Journal of Medical Quality 13 (2): 89-93.
3. Bryk, A., and S. W. Raudenbush. 1992. Hierarchical Linear Models for Social and Behavioral Research: Applications and Data Analysis Methods. Newbury Park, CA: Sage.
4. Charlson, M. E., P. Pompei, K. L. Ales, and C. R. MacKenzie. 1987. "A New Method of Classifying Prognostic Comorbidity in Longitudinal Studies: Development and Validation. "Journal of Chronic Diseases 40 (5): 373-83.
5. Chin, M. H., S. B. Auerbach, S. Cook, J. F. Harrison, J. Koppert, L. Jin, F. Thiel, T. G. Karrison, A. G. Harrand, C. T. Schaefer, H. T. Takashima, N. Egbert, S. C. Chiu, and W. L. McNabb. 2000. "Quality of Diabetes Care in Community Health Centers." American Journal of Public Health 90: 431-4.
6. Committee on Quality Health Care in America, Institute of Medicine. 2000. Crossing the Quality Chasm: A New Health System for the 21st Century, pp 23-3. Washington, DC: National Academy Press.
7. Deyo, R. A., D. C. Cherkin, and M. A. Ciol. "Adapting a Clinical Comorbidity Index for Use with ICD-9-CM Administrative Databases." 1992. Journal of Clinical Epidemiology 45 (6): 613-9.
8. Diabetes Control and Complications Trial Research Group. 1993. "The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes Mellitus." New England Journal of Medicine 329 (14): 977-86.
9. Diggle, P. J., K. Y. Liang, and S. L. Zeger. 1996. The Analysis of Longitudinal Data. Oxford, U.K.: Oxford University Press.
10. Goldstein, H., and D. J. Spiegelhalter. 1996. "League Tables and Their Limitations: Statistical Issues in Comparisons of Institutional Performance." Journal of the Royal Statistical Society Series A 159: 385-443.
11. Harris, M. L., R. C. Eastman, C. C. Cowie, K. M. Flegal, and M. S. Eberhardt. 1999. "Racial and Ethnic Differences in Glycemic Control of Adults with Type 2 Diabetes." Diabetes Care 22 (3): 403-8.
12. Health Plan Employer Data and Information Set (HEDIS®). 2004. [Accessed June 23, 2004]. Available at http://www.ncqa.org/Programs/HEDIS/
13. Hebert, P. L., L. S. Geiss, E. F. Tierney, M. M. Engelgau, B. P. Yawn, and A. M. McBean. 1999. "Identifying Persons with Diabetes Using Medicare Claims Data." American Journal of Medical Quality 14: 270-7.
14. Hsu, J. 1996. Multiple Comparisons: Theory and Methods. 1st edition. Boca Raton, LA: Chapman & Hall/CRC.
15. Iezzoni, L. I. 1997. "Risk and Outcomes." In Risk Adjustment for Measuring Healthcare Outcomes, edited by L. I. Iezzoni, pp 1-42. Chicago: Health Administration Press.
16. Jha, A. K., J. B. Perlin, K. W. Kizer, and R. A. Dudley. 2003. "Effect of the Transformation of the Veterans Affairs Health Care System on the Quality of Care." New England Journal of Medicine 348 (22): 2218-27.
17. Kerr, E. A., D. M. Smith, M. M. Hogan, S. L. Krein, L. M. Pogach, T. P. Hofer, and R. A. Hayward. 2002. "Comparing Clinical Automated, Medical Record, and Hybrid Data Sources for Diabetes Quality Measures." Joint Commission Journal on Quality Improvement 28 (10): 555-55.
18. Liang, K-Y., and S. L. Zeger. 1986. "Longitudinal Data Analysis Using Generalized Linear Models." Biometrika 73: 13-22.
19. Little, R. R., C. L. Rohlfing, H. M. Wiedmeyer, G. L. Myers, D. B. Sacks, and D. E. Goldstein. 2001. "The National Glycohemoglobin Standardization Program: A Five-Year Progress Report." Clinical Chemistry 47: 1985-92.
20. Marshall, E. G., and D. J. Spiegelhalter. 1998. "Reliability of League Tables of In Vitro Fertilisation Clinics: Retrospective Analysis of Live Birth Rates." British Medical Journal 316 (7146): 1701-4.
21. National Glycohemoglobin Standardization Program. 2004. "List of Certified Laboratories" [accessed June 23, 2004]. Available at http://www.missouri. edu/~diabetes/ngsp.html
22. Schneider, E. C., and A. M. Epstein. 1996. "Influence of Cardiac-Surgery Performance Reports on Referral Practices and Access to Care-A Survey of Cardiovascular Specialists." New England Journal of Medicine 335 (4): 251-6.
23. Safford, M., L. Eaton, G. Hawley, M. Brimacombe, M. Rajan, H. Li and L. Pogach. 2003. "Disparities in Use of Lipid-Lowering Medications among People with Type 2 Diabetes Mellitus." Archives of Internal Medicine 163 (8): 922-8.
24. Tahara, Y., and K. Shima. 1995. "Kinetics of HbA1c, Glycated Albumin, and Fructosamine and Analysis of Their Weight Functions against Preceding Plasma Glucose Level." Diabetes Care 18 (4): 440-7.
25. U.K. Prospective Diabetes Study (UKPDS) Group. 1998. "Intensive Blood-Glucose Control with Sulphonylureas or Insulin Compared with Conventional Treatment and Risk of Complications in Patients with Type 2 Diabetes (UKPDS 33)." Lancet 352: 837-53.
26. Weiner, M., and J. Long. 2004. "Cross-Sectional versus Longitudinal Performance Assessments in the Management of Diabetes." Medical Care 42 (2 suppl): II34-9.
27. Wright, A., A. C. Burden, R. B. Paisey, C. A. Cull, and R. R. Holman. 2002. "U.K. Prospective Diabetes Study Group. Sulfonylurea Inadequacy: Efficacy of Addition of Insulin over 6 Years in Patients with Type 2 Diabetes in the U.K. Prospective Diabetes Study;-(UKP-DS 57)." Diabetes Care 25 (2): 330-6.
28. Zhang, Q., M. Safford, J. E. Ottenweller, G. Hawley, D. Repke, J. F. Burgess Jr., S. Dhar, H. Cheng, H. Naito, and L. M. Pogach. 2000. "Performance Status of Health Care Facilities Changes with Risk Adjustment of Hemoglobin A1c." Diabetes Care 23: 919-27.